Amphotericin B
Market
Amphotericin B Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Amphotericin B Market Size and Growth
The global Amphotericin B market is projected to reach a value of USD 570 million by 2025, with a CAGR of 3.5% during the forecast period. Increasing prevalence of fungal infections and growing awareness about antifungal treatments are driving market growth. North America holds the largest market share. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Bristol-Myers Squibb
◍ Jina Pharma
◍ Nanomerics
◍ Matinas BioPharma
◍ Bharat Serums
◍ Nanox
◍ Leadiant Biosciences
◍ Abzena
◍ DNDi
◍ Astellas Pharma
◍ Kadmon Corporation (Eli Lilly and Company)
◍ X-GEN Pharmaceuticals
◍ InterMune
◍ Sterimax Inc
The competitive landscape of the Amphotericin B market includes companies such as Bristol-Myers Squibb, Jina Pharma, Nanomerics, Matinas BioPharma, and others. These companies utilize Amphotericin B for the treatment of fungal infections and contribute to the growth of the market. Some sales revenue figures:
Bristol-Myers Squibb - $26.69 billion, Bharat Serums$150 million, Astellas Pharma - $12.78 billion.
Sample Report
Request
Market Segmentation
By Application
◍ Vaginitis
◍ Candida Infection
◍ Leishmaniasis
◍ Kala-Azar
◍ Cryptococcal Infection
◍ Aspergillus Infection
By Product
◍ Static Drops
◍ Atomization Inhalation
◍ Local Lesion Injection
◍ Other
◍ Other Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients